Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
STAT3 polymorphism can predict the response to interferon-α therapy in patients with metastatic renal cell carcinoma.
Eto M, Kamba T, Miyake H, Fujisawa M, Kamai T, Uemura H, Tsukamoto T, Azuma H, Matsubara A, Nishimura K, Nakamura T, Ogawa O, Naito S; Japan Immunotherapy SNPs-Study Group for Kidney Cancer. Eto M, et al. Among authors: tsukamoto t. Eur Urol. 2013 Apr;63(4):745-52. doi: 10.1016/j.eururo.2012.09.052. Epub 2012 Sep 28. Eur Urol. 2013. PMID: 23063454 Clinical Trial.
Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan.
Eto M, Kawano Y, Hirao Y, Mita K, Arai Y, Tsukamoto T, Hashine K, Matsubara A, Fujioka T, Kimura G, Shinohara N, Tatsugami K, Hinotsu S, Naito S; Japan RCC Trialist Collaborative Group (JRTCG) investigators. Eto M, et al. Among authors: tsukamoto t. BMC Cancer. 2015 Oct 9;15:667. doi: 10.1186/s12885-015-1675-1. BMC Cancer. 2015. PMID: 26452347 Free PMC article. Clinical Trial.
Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy.
Kawano Y, Takahashi W, Eto M, Kamba T, Miyake H, Fujisawa M, Kamai T, Uemura H, Tsukamoto T, Azuma H, Matsubara A, Nishimura K, Nakamura T, Ogawa O, Naito S. Kawano Y, et al. Among authors: tsukamoto t. Cancer Sci. 2016 Jul;107(7):1013-7. doi: 10.1111/cas.12951. Epub 2016 Jun 14. Cancer Sci. 2016. PMID: 27089226 Free PMC article. Clinical Trial.
Recurrence of renal cell carcinoma more than 5 years after nephrectomy.
Uchida K, Miyao N, Masumori N, Takahashi A, Oda T, Yanase M, Kitamura H, Itoh N, Sato M, Tsukamoto T. Uchida K, et al. Among authors: tsukamoto t. Int J Urol. 2002 Jan;9(1):19-23. doi: 10.1046/j.1442-2042.2002.00418.x. Int J Urol. 2002. PMID: 11972645 Free article.
Radical cystectomy for invasive bladder cancer: results of multi-institutional pooled analysis.
Takahashi A, Tsukamoto T, Tobisu K, Shinohara N, Sato K, Tomita Y, Komatsubara S, Nishizawa O, Igarashi T, Fujimoto H, Nakazawa H, Komatsu H, Sugimura Y, Ono Y, Kuroda M, Ogawa O, Hirao Y, Hayashi T, Tsushima T, Kakehi Y, Arai Y, Ueda S, Nakagawa M. Takahashi A, et al. Among authors: tsukamoto t. Jpn J Clin Oncol. 2004 Jan;34(1):14-9. doi: 10.1093/jjco/hyh005. Jpn J Clin Oncol. 2004. PMID: 15020658
2,313 results